• Home
  • Meeting News
    • Pre-Meeeting: March 23
    • NEWS ARCHIVE
      • 2021
      • 2022
  • Attendee Map & Photos
  • Featured Industry Events
    • Satellite Educational Symposia
    • Exhibitor Spotlight Presentations
  • Featured Exhibitors
  • Meeting Home
Get News Updates
REGISTER NOW

  • Plenary speakers explore advances toward precision medicine for immuno-oncology

    Plenary speakers explore advances toward precision medicine for immuno-oncology

    April 13, 2022

    During a plenary session on Tuesday, April 12, four researchers discussed the latest advances in immuno-oncology, including developments in the understanding of immunotherapy modalities, efficacy, and combination strategies. Carl H. June, MD, FAACR, chaired the session.

    READ MORE

  • Researchers report results from four trials of immunotherapy drug combinations

    Researchers report results from four trials of immunotherapy drug combinations

    April 13, 2022

    The Annual Meeting’s final Clinical Trials Plenary Session featured trials of immunotherapy drug combinations that could benefit patients who don’t respond to single-agent immunotherapy or chemotherapy combinations. Timothy A. Yap, MD, PhD, chaired the session.

    READ MORE

  • Schedule highlights from the Program Chair: Wednesday, April 13

    Schedule highlights from the Program Chair: Wednesday, April 13

    April 13, 2022

    Annual Meeting Program Committee Chair Marcia R. Cruz-Correa, MD, PhD, shares a few highlights from Wednesday’s schedule to help plan your day.

    READ MORE

  • Investigators report first disclosures of 12 novel agents during three special sessions

    Investigators report first disclosures of 12 novel agents during three special sessions

    April 13, 2022

    Organized by the AACR Chemistry in Cancer Research working group, this year’s three “New Drugs on the Horizon” sessions featured first disclosures of the discovery and structure of 12 novel agents.

    READ MORE

  • Researchers report promising results from four clinical trials targeting the DNA damage response and KRAS

    Researchers report promising results from four clinical trials targeting the DNA damage response and KRAS

    April 13, 2022

    “There are some very novel drugs targeting the DNA damage response pathway that are being developed, including some presented for the very first time during this session,” said Julie R. Brahmer, MD, MSc, co-chair of the Annual Meeting Clinical Trials Committee.

    READ MORE

  • Douglas R. Lowy, MD, FAACR, enthusiastically steps in as NCI acting director

    Douglas R. Lowy, MD, FAACR, enthusiastically steps in as NCI acting director

    April 13, 2022

    National Cancer Institute Principal Deputy Director Douglas R. Lowy, MD, FAACR, visited the AACR Annual Meeting on Monday, April 11. He becomes NCI acting director at the end of April when Norman E. Sharpless, MD, FAACR, steps down as head of the NCI.

    READ MORE

  • Machine learning models can provide new insights into research data

    Machine learning models can provide new insights into research data

    April 13, 2022

    Trey Ideker, PhD, led a Monday morning session on interpreting and building trust in artificial intelligence models in cancer research. AI techniques hold promise but still lack interpretability and transferability in translational medicine, he said.

    READ MORE


AACR Journals
myAACR
AACR Foundation
AACR Scientific Reports

AACR Blog: Cancer Research Catalyst
Cancer Today® Magazine
Leading Discoveries Magazine

© 2023 American Association for Cancer Research, All Rights Reserved.
Powered By TriStar Event Media, LLC. 

  • Privacy Policy
  • Twitter
  • Facebook
  • LinkedIn
  • YouTube

Get news updates from AACRMeetingNews.org

Subscribe below to get email updates from AACRMeetingNews.org